Applied Therapeutics, Inc.
APLT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $88 | $45 | $71 | $119 |
| - Cash | $12 | $30 | $51 | $79 |
| + Debt | $3 | $3 | $3 | $3 |
| Enterprise Value | $79 | $17 | $23 | $43 |
| Revenue | $1 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $1 | -$10 | -$8 | -$12 |
| % Margin | 100% | – | – | – |
| EBITDA | -$19 | -$23 | -$26 | -$33 |
| % Margin | -1,887.9% | – | – | – |
| Net Income | -$19 | -$21 | -$22 | $44 |
| % Margin | -1,899% | – | – | – |
| EPS Diluted | -0.13 | -0.15 | -0.15 | 0.32 |
| % Growth | 13.3% | 0% | -146.9% | – |
| Operating Cash Flow | -$18 | -$20 | -$29 | -$19 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$18 | -$20 | -$29 | -$19 |